Navigation Links
Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic

CAMBRIDGE, Mass., April 11, 2007 /PRNewswire-FirstCall/ -- Advanced Magnetics today announced positive results from two additional Phase III clinical trials of ferumoxytol as an intravenous (IV) iron replacement therapeutic that are being presented today at approximately 6:00 pm EDT as posters at the National Kidney Foundation's Spring Clinical Meeting in Orlando, Florida. These posters are available in the investor section on the company's web site at http://www.advancedmagnetics.com.

The first poster, "Evaluation of the Efficacy and Safety of Ferumoxytol as an Intravenous Iron Replacement Therapy in Chronic Kidney Disease (CKD) Patients Not on Dialysis" shows results from 303 non-dialysis dependent CKD patients who were randomized to receive either two 510 mg doses of ferumoxytol within one week or 200 mg of oral iron daily for three weeks. This Phase III study demonstrated a statistically significant achievement of all primary and secondary endpoints. Additionally, all primary and secondary endpoints were achieved with statistical significance in both patients on erythropoiesis stimulating proteins (ESP) and those not on ESPs. These new results are consistent with the results previously presented at the American Society of Nephrology's Renal Week in San Diego, CA in November 2006 from another study in non-dialysis dependent CKD patients with an identical protocol.

The second poster, "Evaluation of the Safety of Intravenous Ferumoxytol for Iron Replacement Therapy in Chronic Kidney Disease (CKD)" shows results from a double-blind, placebo-controlled, crossover Phase III study which enrolled a total of 750 patients, including both dialysis-dependent CKD patients and non-dialysis dependent CKD patients, who received either one 510 mg dose of ferumoxytol or IV placebo (saline) at day zero and received the other treatment at day seven.
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
(Date:8/29/2014)... , Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care blood instrumentation and consumables to the medical, research ... , Chairman and Chief Executive Officer, will present at ... Conference 2014 on Tuesday, September 9, 2014 at 12:30 ... Omni Berkshire Place Hotel in New York ...
(Date:8/29/2014)... Columbia and MENLO PARK, Calif. ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") ... year-end financial statements.  The Company recently changed its fiscal ... an application to list its common stock on a ... DelMar,s financial statements as filed with the United ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Orthopedic Soft Tissue Repair Devices Market 2014-2018" ... tissues are the mass of cells that connect, support, ... soft tissues such as tendons, ligaments, cartilage, fascia, and ... degeneration of these tissues with age result in wear ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3
... (NASDAQ: STAA ), a leading developer, manufacturer and ... its presentation time at the 13 th Annual B. ... be on Wednesday, May 23, 2012 now ... Caldwell, President and CEO, will review the company,s recent financial ...
... 2012  Savvy vice presidents and directors across all ... organizational structures, critical activities, proven processes, and investment ... "In today,s increasingly competitive health ... have analysis from across the worldwide marketplace," says ...
Cached Medicine Technology:B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference 2Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making 2
(Date:8/29/2014)... Daily Gossip reveals in its Stop Sciatica in 8 Minutes ... curing this disease. , The program promises to be ... only one week. This is described as a unique way ... , Moreover, with this new method patients might be ... just 8 minutes. , Interested customers can check the ...
(Date:8/29/2014)... The new review that can be read on DailyGossip.org ... that will permanently eliminate the symptoms of this disease. , ... a cure in as fast as 30 to 60 days. ... one week. , The Tinnitus Miracle review indicates that ... hearing loss, pain in the ear and dizziness. Read the ...
(Date:8/29/2014)... August 29, 2014 Cosmetic Town ... industry’s most notable plastic surgeons with prospective patients. ... about cutting edge techniques in plastic and reconstructive ... contain the most reliable information for general readers, ... treatment.     , Cosmetic Town began featuring renowned cosmetic ...
(Date:8/29/2014)... August 29, 2014 The Nasal ... reveals that the new program is actually based ... method was created by a former nasal polyps ... overcome the disturbing problem. Manuel Richards suffered from ... this system. , Learn more about Manuel ...
(Date:8/29/2014)... FL (PRWEB) August 29, 2014 The ... anxiously awaited final rule (file code CMS–0052–P) today allowing ... using the 2011 Edition Certified EHR Technology (CEHRT) or ... Eligible Professionals (EPs) who have not been able to ... reporting period in 2014 can continue to use 2011 ...
Breaking Medicine News(10 mins):Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:Cosmetic Town Is Now Connecting Patients with Qualified Cosmetic Specialists 2Health News:Nasal Polyps Treatment Miracle Review Exposes New Natural and Permanent Healing Program 2Health News:Quirk Healthcare Outlook on MU2 Delay Confirmation 2
... , WASHINGTON , Jan. 13 Bradley C. ... A. Mrusek , a resident of Maineville, Ohio , pleaded guilty late ... R. Barrett in Cincinnati , the Justice Department and Internal Revenue ... wer e i n d icted ...
... is the key, say researchers working with mice , ... giving scientists a greater understanding of how a brain ... level and why some people are resistant to antidepressants. ... stressful life events -- cause the mental disorders. Antidepressants ...
... complete agenda for the Seventh International Chronic ... online at http://www.ctosummit.org/overview/agenda.html . The CTO ... technologies, research findings and new developments in ... optimize success in chronic total coronary occlusions. ...
... , ... and BioScience Laboratories, Inc. announced a formal partnership to provide fully integrated topical clinical ... a single source for outsourcing clinical trials. , ... Wareham, MA (PRWEB) January 13, 2010 -- Synomics Pharma ...
... ... Hepregen’s Previous NIH Funding and Continued Development of the Company’s Platform for Advanced Toxicity ... ... Corporation, a leading provider of bioengineered solutions for drug development, announced today that it ...
... N.H. , Jan. 13 Eleme Medical Inc., ... announced today that they will be conducting a global contest ... of SmoothShapes . An alternative to celebrity endorsement, the campaign,s ... real women who experienced SmoothShapes cellulite and BodySlimming™ treatments, letting ...
Cached Medicine News:Health News:Two Cincinnati Dentists Plead Guilty to Conspiracy, Tax Evasion on Eve of Trial 2Health News:Chronic total occlusion strategies will be discussed during national summit February 4-5 2Health News:Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services 2Health News:Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services 3Health News:Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update at OneMed Forum 2Health News:Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update at OneMed Forum 3Health News:Eleme Medical Announces The Real Women of SmoothShapes(R) Campaign 2Health News:Eleme Medical Announces The Real Women of SmoothShapes(R) Campaign 3
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Medicine Products: